Parker Waichman LLP Files Lawsuits on Behalf of Women who Allegedly Suffered Permanent Injury, Permanent and Substantial Physical Deformity, and Loss of Bodily Organ Systems Following Implantation

LOUISVILLE, Colo., Dec. 7, 2010 /PRNewswire/ -- Two of the organizations named to the Gartner "The Healthcare Supply Chain Top 25 for 2010"* will be featured in a webinar highlighting how they are leveraging supply chain excellence to optimize business and clinical performance.

CHICAGO - U.S. doctors haven't seen a new drug-coated stent heart device for years, but that could change soon if the Endeavor stent from Medtronic Inc. wins U.S. regulatory approval. The Minneapolis-based company expects approval by the end of this year.

Drug-oozing heart stents became the fastest-selling medical device in modern history - and a cash cow for Johnson & Johnson and Boston Scientific Corp. - because of the device's ability to prevent scar tissue from forming new blockages after artery-clearing surgery.

By Stephen Heuser, The Boston Globe Jul. 21--With sales of its top medical devices continuing to drop, Boston Scientific Corp. plans broad job cuts that could affect its Massachusetts employees, a spokesman said yesterday.